92 related articles for article (PubMed ID: 10610411)
1. Cell cycle regulatory proteins in glomerular disease.
Shankland SJ
Kidney Int; 1999 Oct; 56(4):1208-15. PubMed ID: 10610411
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids stimulate p21(CIP1) in mesangial cells and in anti-GBM glomerulonephritis.
Terada Y; Okado T; Inoshita S; Hanada S; Kuwahara M; Sasaki S; Yamamoto T; Marumo F
Kidney Int; 2001 May; 59(5):1706-16. PubMed ID: 11318941
[TBL] [Abstract][Full Text] [Related]
3. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle control in glomerular disease.
Wolf G; Shankland SJ
Prog Cell Cycle Res; 2003; 5():71-9. PubMed ID: 14593702
[TBL] [Abstract][Full Text] [Related]
5. Podocyte expression of the CDK-inhibitor p57 during development and disease.
Hiromura K; Haseley LA; Zhang P; Monkawa T; Durvasula R; Petermann AT; Alpers CE; Mundel P; Shankland SJ
Kidney Int; 2001 Dec; 60(6):2235-46. PubMed ID: 11737597
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle control in glomerular disease.
Griffin SV; Pichler R; Dittrich M; Durvasula R; Shankland SJ
Springer Semin Immunopathol; 2003 May; 24(4):441-57. PubMed ID: 12778338
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis.
Shankland SJ; Wolf G
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F515-29. PubMed ID: 10751212
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle and glomerular disease: a minireview.
Marshall CB; Shankland SJ
Nephron Exp Nephrol; 2006; 102(2):e39-48. PubMed ID: 16179806
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.
Tomita N; Kim JY; Gibbons GH; Zhang L; Kaneda Y; Stahl RA; Ogborn M; Venderville B; Morishita R; Baran D; Dzau VJ
Int J Mol Med; 2004 May; 13(5):629-36. PubMed ID: 15067361
[TBL] [Abstract][Full Text] [Related]
10. IGF-1 increases laminin, cyclin D1, and p21Cip1 expression in glomerular mesangial cells: an investigation of the intracellular signaling pathway and cell-cycle progression.
Jiang Y; Cheng DW; Levi E; Singh LP
J Cell Biochem; 2006 May; 98(1):208-20. PubMed ID: 16408277
[TBL] [Abstract][Full Text] [Related]
11. The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis.
Kim YG; Alpers CE; Brugarolas J; Johnson RJ; Couser WG; Shankland SJ
Kidney Int; 1999 Jun; 55(6):2349-61. PubMed ID: 10354282
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanism in glomerular mesangial cell proliferation.
Haas CS; Schöcklmann HO; Lang S; Kralewski M; Sterzel RB
J Nephrol; 1999; 12(6):405-15. PubMed ID: 10626832
[TBL] [Abstract][Full Text] [Related]
13. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
[TBL] [Abstract][Full Text] [Related]
14. Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells.
Mitchell D; Rodgers K; Hanly J; McMahon B; Brady HR; Martin F; Godson C
Am J Pathol; 2004 Mar; 164(3):937-46. PubMed ID: 14982847
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
16. Effect of Smad pathway activation on podocyte cell cycle regulation: an immunohistochemical evaluation.
Koutroutsos K; Kassimatis TI; Nomikos A; Giannopoulou I; Theohari I; Nakopoulou L
Ren Fail; 2014 Sep; 36(8):1310-6. PubMed ID: 25026939
[TBL] [Abstract][Full Text] [Related]
17. Expression of cell cycle regulatory factors in differentiating osteoblasts: postproliferative up-regulation of cyclins B and E.
Smith E; Frenkel B; Schlegel R; Giordano A; Lian JB; Stein JL; Stein GS
Cancer Res; 1995 Nov; 55(21):5019-24. PubMed ID: 7585545
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.
Terada Y; Inoshita S; Nakashima O; Tamamori M; Ito H; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Aug; 56(2):494-501. PubMed ID: 10432388
[TBL] [Abstract][Full Text] [Related]
19. The role of cell cycle proteins in Glomerular disease.
Griffin SV; Pichler R; Wada T; Vaughan M; Durvasula R; Shankland SJ
Semin Nephrol; 2003 Nov; 23(6):569-82. PubMed ID: 14631565
[TBL] [Abstract][Full Text] [Related]
20. Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation?
Eng E; Floege J; Young BA; Couser WG; Johnson RJ
Kidney Int Suppl; 1994 Feb; 45():S45-7. PubMed ID: 8158896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
